Why to choose Rispoval RS+Pi3 Intranasal?
Rispoval RS+Pi3 IntraNasal is a single dose at 9 days of age with protection against RSV as early as 14 days of age. Vaccine B3 - 2 dose vaccination course completed at 42 days of age with highest antibody immunity not achieved until day 56. Rispoval RS+Pi3 Intranasal provides proven RSV and Pi3 protection earlier and longer than vaccine B.

Graphic based on product SPCs: Vaccine B (MSD) and Rispoval RS+Pi3 Intranasal
1 The duration of protective immunity against Pi3 may be reduced in MDA calves vaccinated before 3 weeks of age
2 The magnitude of the antibody response may be reduced by maternally derived antibodies in calves up to six weeks (42 days) of age
3 The duration of protective immunity has not been established in challenge experiments for Vaccine B
Learn more in following videos ...
Intranasal Administration

|
|
Mode of Action

|